MDX-1379

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MDX-1379, covering 2011-06-23 to 2011-06-23. Get the full timeline:

Most recent: Clinical Trial Update: MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma [Phase 3]

See pricing